These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31240525)

  • 21. Chordoma of the skull base: predictors of tumor recurrence.
    Pallini R; Maira G; Pierconti F; Falchetti ML; Alvino E; Cimino-Reale G; Fernandez E; D'Ambrosio E; Larocca LM
    J Neurosurg; 2003 Apr; 98(4):812-22. PubMed ID: 12691407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic and transcriptomic characterization of skull base chordoma.
    Sa JK; Lee IH; Hong SD; Kong DS; Nam DH
    Oncotarget; 2017 Jan; 8(1):1321-1328. PubMed ID: 27901492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas.
    Lin E; Scognamiglio T; Zhao Y; Schwartz TH; Phillips CD
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1509-1514. PubMed ID: 29903925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
    Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H
    BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
    Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
    J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect comparisons among treatment measures on progression-free survival in patients with skull base chordomas: a retrospective study of 234 post-surgical cases.
    Wang L; Tian K; Ma J; Wang K; Jia G; Wu Z; Zhang L; Zhang J
    Acta Neurochir (Wien); 2017 Oct; 159(10):1803-1813. PubMed ID: 28699066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma.
    Tosuner Z; Bozkurt SU; Kiliç T; Yilmaz B
    Turk Patoloji Derg; 2017; 33(2):112-120. PubMed ID: 28272674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence.
    Deniz ML; Kiliç T; Almaata I; Kurtkaya O; Sav A; Pamir MN
    Neurosurgery; 2002 Sep; 51(3):753-60; discussion 760. PubMed ID: 12188955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis.
    Sakai K; Hongo K; Tanaka Y; Nakayama J
    Brain Tumor Pathol; 2007; 24(2):57-62. PubMed ID: 18095132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
    La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
    Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of brachyury expression in chordomas.
    Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G
    Ann Diagn Pathol; 2021 Aug; 53():151760. PubMed ID: 33989961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-transcriptome analysis of chordoma of the skull base.
    Bell D; Raza SM; Bell AH; Fuller GN; DeMonte F
    Virchows Arch; 2016 Oct; 469(4):439-49. PubMed ID: 27401718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics, immunohistochemistry, and outcomes of 77 patients with skull base chordomas.
    Ouyang T; Zhang N; Zhang Y; Jiao J; Ren J; Huang T; Chen J
    World Neurosurg; 2014; 81(5-6):790-7. PubMed ID: 23298670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma.
    Feng Y; Shen J; Gao Y; Liao Y; Cote G; Choy E; Chebib I; Mankin H; Hornicek F; Duan Z
    Oncotarget; 2015 May; 6(13):11139-49. PubMed ID: 25871477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mandibular metastasis as a presenting feature of a clival chordoma.
    Krishnamurthy A
    J Cancer Res Ther; 2020; 16(3):668-671. PubMed ID: 32719288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pathological features of intradural retroclival chordoma.
    Wang L; Wu Z; Tian K; Li G; Zhang J
    World Neurosurg; 2014 Nov; 82(5):791-8. PubMed ID: 23416632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies.
    Gellner V; Tomazic PV; Lohberger B; Meditz K; Heitzer E; Mokry M; Koele W; Leithner A; Liegl-Atzwanger B; Rinner B
    Sci Rep; 2016 Apr; 6():24195. PubMed ID: 27072875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma.
    Akhavan-Sigari R; Abili M; Gaab MR; Rohde V; Zafar N; Emami P; Ostertag H
    Neurosurg Rev; 2015 Jan; 38(1):89-98; discussion 98-9. PubMed ID: 25323095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chordoma: Genetics and Contemporary Management.
    Desai R; Pelargos PE; Dunn IF
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.